Literature DB >> 20621202

Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.

Rohit Loomba1, Hwai-I Yang, Jun Su, David Brenner, Uchenna Iloeje, Chien-Jen Chen.   

Abstract

BACKGROUND & AIMS: Body mass index (BMI) and alcohol use are risk factors for hepatocellular carcinoma (HCC). We performed a prospective study to determine if these factors have synergistic effects on HCC risk.
METHODS: Over 14 years, we followed up 2260 Taiwanese men from the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-Hepatitis B Virus (REVEAL-HBV) Study Cohort who tested positive for the hepatitis B surface antigen (mean age, 46 ± 10 y; mean BMI, 24 ± 3 kg/m(2)); 20% reported alcohol use. Incident HCC cases were identified via linkage to the national cancer registry. Multivariate-adjusted hazard ratio (HR) and 95% confidence interval (CI) were estimated using Cox-proportional hazards models.
RESULTS: In univariate analysis, the interaction between BMI and alcohol predicted incident HCC (P = .029). Alcohol use and extreme obesity (BMI ≥30 kg/m(2)) had synergistic effects on the risk of incident HCC in analyses adjusted for age (HR, 3.41; 95% CI, 1.25-9.27; P < .025) and multivariables (HR, 3.40; 95% CI, 1.24-9.34; P < .025). The relative risk estimate for the interaction and the attributable proportion from the interaction and synergy index were 1.59, 0.52, and 4.40, respectively; these indicate a multiplicative interaction between alcohol use and extreme obesity. In an analysis stratified into 4 World Health Organization categories of BMI and alcohol use, the risk of incident HCC increased in overweight (HR, 2.4; 95% CI, 1.3-4.4), obese (HR, 2.0; 95% CI, 1.1-3.7), and extremely obese (HR, 2.9; 95% CI, 1.0-8.0) users of alcohol (P for trend = .046).
CONCLUSIONS: Obesity and alcohol have synergistic effects to increase the risk of incident HCC in hepatitis B surface antigen-positive men. Lifestyle interventions might reduce the incidence of HCC.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621202     DOI: 10.1016/j.cgh.2010.06.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 2.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

3.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

Review 4.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity.

Authors:  Amy R Johnson; J Justin Milner; Liza Makowski
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

5.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Authors:  Rohit Loomba; Hwai-I Yang; Jun Su; David Brenner; Elizabeth Barrett-Connor; Uchenna Iloeje; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2013-01-24       Impact factor: 4.897

Review 6.  Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.

Authors:  Hayato Nakagawa
Journal:  World J Hepatol       Date:  2015-08-18

7.  Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

Authors:  Rohit Loomba; Jessica Liu; Hwai-I Yang; Mei-Hsuan Lee; Sheng-Nan Lu; Li-Yu Wang; Uchenna H Iloeje; San-Lin You; David Brenner; Chien-Jen Chen
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382

8.  Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo.

Authors:  Kyle J Thompson; Ryan Z Swan; Tracy L Walling; David A Iannitti; Iain H McKillop; David Sindram
Journal:  Surg Endosc       Date:  2013-03-07       Impact factor: 4.584

9.  Controversies in the Diagnosis and Management of NAFLD and NASH.

Authors:  Mary E Rinella; Rohit Loomba; Stephen H Caldwell; Kris Kowdley; Michael Charlton; Brent Tetri; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-04

Review 10.  Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations.

Authors:  Richard Parker; Seung-Jin Kim; Bin Gao
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.